---

Effect of Si-Miao-Yong-An on the stability of atherosclerotic plaque in a diet-induced rabbit model

Authors Peng, Li; Li, Ming; Xu, Ying-zhi; Zhang, Guang-yin; Yang, Cui; Zhou, Ya-nan; Li, Liang-jun; Zhang, Jun-ping

Journal JOURNAL OF ETHNOPHARMACOLOGY , AUG 30 2012,1:143

DOI 10.1016/j.jep.2012.06.030 PubMed 22750436

Abstract Ethnopharmacological relevance: Si-Miao-Yong-An (Trade name: Mai-Luo-Ning), a Chinese herbal formulation comprising Flos Lonicerae Japonicae, Radix Scrophulariae Ningpoensis, Radix Angelicae Sinensis and Radix Glycyrrhizae Uralensis, has been used in treating ischemic cardiovascular and cerebrovascular diseases for many years. Clinical and experimental studies have shown that Si-Miao-Yong-An can inhibit the inflammatory response and antagonize the blood clotting process.Aim of the study: To investigate the effect of Si-Miao-Yong-An on atherosclerotic plaque stability in rabbit model.Materials and methods: Seventy male rabbits were divided into four groups. Rabbits in the normal group were fed with normal diet, while rabbits in model group and drug treatment groups were fed with high cholesterol diet, underwent BSA-induced immunologic injury and balloon-induced mechanical injury. After atherosclerotic rabbits were treated with simvastatin or Si-Miao-Yong-An for 16 weeks, blood and aorta in four groups were collected for analysis.Results: Si-Miao-Yong-An reduced the level of triglycerides (TG) and low-density lipoprotein cholesterol (LDL-C) in blood after treatment for 16 weeks. Compared with model group, Si-Miao-Yong-An decreased the content of many inflammatory cytokines in blood and plaque. Morphological analysis of abdominal aorta showed that Si-Miao-Yong-An increased fibrous cap thickness and smooth muscle cells, reduced lipid core area and macrophages, and contributed to inhibit matrix degradation and inflammatory response.Conclusion: In this study, we provided evidence for that Si-Miao-Yong-An could promote the stability of atherosclerotic plaque in the rabbit model, indicating that this medicine was a reasonable drug treating cardiovascular diseases in clinical. (C) 2012 Elsevier Ireland Ltd. All rights reserved.

Species covered 忍冬属 Lonicera 甘草属 Glycyrrhiza